Since the temporal changes in systemic HMGB1 levels during the course of infection with various strains of influenza virus had not been previously examined, we sought to establish whether an association of HMGB1 release with influenza virus infection progression existed and, if it did, whether this information could be used to define subsequent therapies. This evidence concerns the gene HMGB1 and infection.